Facilitator:  Peter Gunter   

Scribe: Robin Isgett  


Antitrust Statement

Professional Associations, such as HL7, which bring together competing entities are subject to strict 
scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote 
fairness in competition and, as such, supports laws against monopoly and restraints of trade and their 
enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is 
responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of 
the Governance and Operations Manual (GOM).

Agenda Topics

Agenda Outline

Agenda Item

Meeting Minutes from Discussion

Decision Link


HL7 ANSI Anti-Trust Policy

HL7 adheres to the ANSI Anti-Trust policy.  We should avoid sharing any information on this call that could be interpreted as anti-competitive.  If there are topics that you don’t normally speak about in other public settings, such as conferences or trade shows, then it’s probably best to save those topics for another time as this is a public call. If you have any questions you can refer to the GOM section 05.01 or consult your companies legal division.

Peter read anti-trust statement.

 Minutes Approval  -   Feb 21, 2023 Weekly WG meeting.  

Minutes Approval -Feb 28 Weekly WG meeting

Peter motioned to approve minutes for 02/21/23, Christol seconded.  Approved by consent.  Technical difficulties prevented co-chair from officiating the meeting on 02/28/23.  Peter motioned to approve minutes and Chris Cioffi seconded.  Approved by consent. 

New Proposals and PSS for review - PIE comments of interest

  1. Project Proposals:  

    Adverse Event Clinical Research Implementation Guide.

  2. Project Scope Statements

PSS 2170 - School Based Physical.  The PIE commented that the WG would like to get an overview of this project.  Request that they join a WG call to discuss questions, such as, Will the students be identified? Is there some type of matching of the student to a health plan or provider?  Possible SDOH risk assessment.

PSS 2149 - AI Data Life Cycle.  PIE commented that we are not an interested party at this time.


2023May Announcement of Formation of Consensus Group

  • Health Level Seven International® invites you to take part in the formation of consensus groups for balloting HL7 candidate standards and documents prior to the upcoming May 2023 ballot cycle. 
  • Recent changes to ANSI’s Essential Requirements eliminate Affiliates as well as Associations as an interest type for balloting (this does not affect membership type). Beginning with the September 2022 ballot cycle, if your organization falls under the Government/Professional Associations/Universities membership category, it will display as General Interest type for purposes of balloting. With the 2023 May ballot cycle, Affiliate voting members will also fall into this category.

  • Consensus Group Sign-Up Open Date: Monday, February 27, 2023
  • Consensus Group Sign-Up Close Date: Thursday, March 30, 2023

Important Note: Consensus group signup closes when ballot voting begins. 

Consensus group enrollment will be available from a date at least four weeks preceding the ballot vote opening date and will continue until the opening of voting.  While the exact dates are dependent upon individual ballot open and close dates, in general the consensus group signup period dates are as follows:

Reviewed announcements.

ManagementViet Nguyen MD will join our PIE WG call at 2:30 pm to socialize this work with Questionnaire and example use cases20230301 CDex Scenarios.pptx
Complete Prior Authorization CommentsContinue discussion using NPRM discussion guide.  
  • Left off at Burden reduction, so this will be the starting point.

Comments were sent as is:

PIE WG Healthcare Attachments NPRM Discussion Guide revised (2-21-2023).docx

Update CDex

Viet Nguyen socialization of Questionnaire

We gained approval to move forward with building out example sets with Clinical Data Exchange CDex last week at DV member meeting.  I’m introducing all of you to additional PMO, Crystal Kallem, our partner and Project Manager for DV use case work, and our two existing CDex leads, Christol Green and Durwin Day. Yan Heras is our deputy tech director on this use case and will be helping to define how and where we capture examples.

You are here because have either expressed interest or offered up connections to MD/provider support on this work in the past.  The group is slowly getting organized, so want to make sure you know each other, so you can join calls/send colleagues our way in the coming weeks.

Team, Drs. Waldren, Suarez, Lane and Giannulli are active members of Da Vinci’s Clinical Advisory as well as each seen as thought leaders/drivers for clinical data exchange in the industry. Their collective practical knowledge here is priceless.

See Powerpoint document.
Open FloorNew LOINC code suggested by Bob Dieterle to add to the HIPAA tab.

Use of CDex, DTR and FHIR.  The LOINC code would be to request a questionnaire for a prior auth.  Discussion regarding EHRs and Payers.  Rachel motioned that we approve the request.  Bob seconded the motion.

VOTE:  13-0-1

Management Next agenda


Adjourned at 3:33 PM EST

  Supporting Documents

Outline Reference

Supporting Document

Minute Approval

Action items